Ravi Majeti, MD, PhD
Associate Professor at Stanford University
2011 NYSCF – Robertson Stem Cell Investigator Alumnus
MD, University of California, San Francisco
PhD, University of California, San Francisco
Postdoctoral Training, Stanford University
Dr. Majeti has focused on finding an alternative strategy of killing cancer stem cells in acute myeloid leukemia (AML), an aggressive type of blood cancer. He has had success in using a treatment where cells target CD47, a protein found on many cancer stem cells, and is now pursuing clinical trials to eradicate cancers like AML. He and his lab aim to not just bring about remission, but also eliminate any relapses in patients.